Generative Active Learning for the Search of Small-molecule Protein Binders
Authors:
Maksym Korablyov,
Cheng-Hao Liu,
Moksh Jain,
Almer M. van der Sloot,
Eric Jolicoeur,
Edward Ruediger,
Andrei Cristian Nica,
Emmanuel Bengio,
Kostiantyn Lapchevskyi,
Daniel St-Cyr,
Doris Alexandra Schuetz,
Victor Ion Butoi,
Jarrid Rector-Brooks,
Simon Blackburn,
Leo Feng,
Hadi Nekoei,
SaiKrishna Gottipati,
Priyesh Vijayan,
Prateek Gupta,
Ladislav Rampášek,
Sasikanth Avancha,
Pierre-Luc Bacon,
William L. Hamilton,
Brooks Paige,
Sanchit Misra
, et al. (9 additional authors not shown)
Abstract:
Despite substantial progress in machine learning for scientific discovery in recent years, truly de novo design of small molecules which exhibit a property of interest remains a significant challenge. We introduce LambdaZero, a generative active learning approach to search for synthesizable molecules. Powered by deep reinforcement learning, LambdaZero learns to search over the vast space of molecu…
▽ More
Despite substantial progress in machine learning for scientific discovery in recent years, truly de novo design of small molecules which exhibit a property of interest remains a significant challenge. We introduce LambdaZero, a generative active learning approach to search for synthesizable molecules. Powered by deep reinforcement learning, LambdaZero learns to search over the vast space of molecules to discover candidates with a desired property. We apply LambdaZero with molecular docking to design novel small molecules that inhibit the enzyme soluble Epoxide Hydrolase 2 (sEH), while enforcing constraints on synthesizability and drug-likeliness. LambdaZero provides an exponential speedup in terms of the number of calls to the expensive molecular docking oracle, and LambdaZero de novo designed molecules reach docking scores that would otherwise require the virtual screening of a hundred billion molecules. Importantly, LambdaZero discovers novel scaffolds of synthesizable, drug-like inhibitors for sEH. In in vitro experimental validation, a series of ligands from a generated quinazoline-based scaffold were synthesized, and the lead inhibitor N-(4,6-di(pyrrolidin-1-yl)quinazolin-2-yl)-N-methylbenzamide (UM0152893) displayed sub-micromolar enzyme inhibition of sEH.
△ Less
Submitted 2 May, 2024;
originally announced May 2024.
Graph-Based Active Machine Learning Method for Diverse and Novel Antimicrobial Peptides Generation and Selection
Authors:
Bonaventure F. P. Dossou,
Dianbo Liu,
Xu Ji,
Moksh Jain,
Almer M. van der Sloot,
Roger Palou,
Michael Tyers,
Yoshua Bengio
Abstract:
As antibiotic-resistant bacterial strains are rapidly spreading worldwide, infections caused by these strains are emerging as a global crisis causing the death of millions of people every year. Antimicrobial Peptides (AMPs) are one of the candidates to tackle this problem because of their potential diversity, and ability to favorably modulate the host immune response. However, large-scale screenin…
▽ More
As antibiotic-resistant bacterial strains are rapidly spreading worldwide, infections caused by these strains are emerging as a global crisis causing the death of millions of people every year. Antimicrobial Peptides (AMPs) are one of the candidates to tackle this problem because of their potential diversity, and ability to favorably modulate the host immune response. However, large-scale screening of new AMP candidates is expensive, time-consuming, and now affordable in develo** countries, which need the treatments the most. In this work, we propose a novel active machine learning-based framework that statistically minimizes the number of wet-lab experiments needed to design new AMPs, while ensuring a high diversity and novelty of generated AMPs sequences, in multi-rounds of wet-lab AMP screening settings. Combining recurrent neural network models and a graph-based filter (GraphCC), our proposed approach delivers novel and diverse candidates and demonstrates better performances according to our defined metrics.
△ Less
Submitted 18 September, 2022;
originally announced September 2022.